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A B S T R A C T
The Reg IV gene has been documented in the colon, small intestine, stomach and pancreas of the human. Expression
of the Reg IV in different cell types has been associated with regeneration, cell growth and cell survival, cell adhesion and
resistance to apoptosis. It is unknown whether the Reg IV protein is present in the normal rat tissue. The aim of this
study was to reveal the expression of the Reg IV protein in the rat spleen and colon. Western blot analysis using antibody
specific for Reg IV protein were performed on rat spleen and colon extracts. Low level of Reg IV expression was found in
all examined colon samples. The expression of Reg IV protein in spleen tissue was significantly higher than in the colon.
Reg IV protein was immunohistochemically stained in a few epithelial cells in the basal portion of colon crypts and in a
large spleen cells which were scattered in the red pulp. Our results demonstrate for the first time the presence of the Reg
IV protein expression in the healthy spleen and colon tissue of the rat. Other members of the Reg family, Reg I and Reg III
proteins have been shown to act as a growth factors in gastrointestinal tract, but without further experiments we can only
assume the potential role of the Reg IV protein in spleen and colon cell growth.
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Introduction
In 1988, Terazono et al.1 first isolated a gene ex-
pressed in regenerating pancreatic b cells which he na-
med regenerating gene (Reg). Several reg and reg-related
genes have been isolated from human, rat and mouse tis-
sue and they constitute a multigene family, the Reg gene
family. Based on the primary structure of the proteins
encoded by Reg family genes, the members of the Reg
family were grouped into three subclasses, type I, II and
III2. Reg I was originally isolated from a rat regenerating
islet-derived complementary DNA (cDNA) library. The
sequence of the rat Reg I gene encodes a 165 amino acid
protein, with a 21 amino acid signal peptide1. Activation
of Reg family proteins is induced by proinflammatory
citokines such as interleukin-6 and different growth fac-
tors such as hepatocite growth factor (HGF) and epider-
mal growth factor (EGF) which are involved in regenera-
tion process of many organs3,4. Reg I protein acts as a
growth factor for pancreatic b cells in an autocrine/pa-
racrine manner2. Except in the pancreatic tissue, Reg I
protein expression has also been found in the gastroin-
testinal tissues and kidney5. Reg II has been found only
in mice. The expression of Reg III is stimulated following
motor neuron injury and acts as a Schwann cell mitogen
during nerve regeneration6. Reg III is also expressed in
hepatocellular carcinomas and during acute pancreatitis,
suggesting a significant role as a growth factor in alimen-
tary tract and pancreatic acinar cells and neuronal cells7.
Recently identified Reg IV gene and discovered that ex-
pression of Reg IV messenger RNA (mRNA) in human
tissues was higher in the colon, small intestine, stomach
and pancreas8. Reg IV is also expressed in colorectal
adenocarcinoma9, pancreatic cancer10, gastric adenocar-
cinoma11, prostate adenocarcinoma12 and in inflamma-
tory bowel disease13. It is unknown whether the Reg IV
protein is expressed in various types of rat tissues. There
is a single study investigating Reg IV gene expression in
injured motor neurons after axotomy of the rat hypo-
glossal nerve14. The aim of this study was to investigate
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whether Reg IV protein is expressed in two structurally
and functionally different rat organs. The spleen is pa-
renchymal organ and one of the centers of activity of the
reticuloendothelial system which is a part of the immune
system. The colon is a part of digestive system responsi-
ble for nutrient absorption. Moreover, the purpose of this
investigation was to quantify the level of Reg IV expres-
sion in these two organs.
Materials and Methods
Rat tissue specimens
Six healthy male Wistar rats weighing 250–300 g were
obtained from Institute for Medical Research in Zagreb.
The animals were housed in a pathogen-free environ-
ment and allowed food and water ad libitum. The ani-
mals received human care in compliance with the local
ethic committee. The animals were killed by an overdose
of diethyl ether anesthesia. Fragment of the spleen and
colon samples were excised and immediately frozen in
liquid nitrogen and stored at –80 °C until extraction of
protein.
Western blot analysis
Tissues were homogenized in lysis buffer with 50
mmol/L of Tris-HCl buffer (pH 8.0) containing 100 mg/mL
of the protease inhibitor PMSF, and then a 2 mL protease
inhibitor coctail (Sigma-Aldrich Corporation, Missouri,
USA) was added. The tissue were centrifuged at 2,000 ´ g
for 30 min at 4 °C, and the supernatant containing total
proteins was used in further tests. Fifty micrograms of
protein estimated by the Bradford method was submit-
ted to 15% SDS-PAGE and transferred to a polyvinyli-
dene fluoride (PVDF) membrane. The membrane was
blocked in 5% skim milk in TBS containing 0.05% Tween-
-20 for 2 hours, and then incubated for 16 hours with
1:200 dilution of goat anti-Reg IV polyclonal antibody
(Santa Cruz Biotechnology, Inc., California, USA) at a
temperature of 4 °C. After washing four times in TBS,
the blots were reacted with 1:2000 dilution of horseradish
peroxidase-conjugated donkey antigoat Ig (Santa Cruz
Biotechnology, Inc., California, USA) at room tempera-
ture for 2 hours. After washing four times in TBS, the
signals were visualized using enhanced chemilumine-
scence reagents (ECL; Amersham, Buckinghamshire, UK).
The PVDF membrane exposition started 2 minutes after
the detection reagent was added and lasted for 10 min-
utes. The signal intensity of the protein product was
quantified by densitometry (Kodak Image Station 440,
LabImage, Halle, Germany).
Immunohistochemistry for Reg IV
The cryostat sections were prepared on glass slides
with a 5 mm thickness. For Immunohistochemistry, sec-
tions were fixed in cold acetone at 4 °C for 10 min. Endog-
enous peroxidase activity was blocked with 0.3% hydro-
gen peroxide in methanol for 30 min. After incubation in
normal blocking serum for 30 min, sections were incu-
bated with primary goat anti-Reg IV polyclonal antibody
(Santa Cruz Biotechnology, Inc., California, USA) over-
night at 4 °C in a humified environment. After washing
in PBS-Tween 20 for 3 ´ 5 min, the sections were incu-
bated with secondary antibody at room temperature for
30 min (Streptavidin/HRP; DAKO, Denmark) according
to the manufacturer’s instructions. Antibodies were vi-
sualized with 3,3’-diaminobenzidine tetra hydrochloride.
Statistics
Results were expressed as the X ± SEM. Statistical
analysis was performed using Student’s t-test. Differ-
ences were considered significant when p were less than
0.05.
Results
We studied the expression of the Reg IV protein in the
rat spleen and colon which are the organs with different
structure and function. Western blot analysis with anti-
-Reg IV antibody detected Reg IV as a 20 kilodalton
(kDa) protein in the spleen and colon extracts (Figure 1).
The expression of Reg IV protein in spleen tissue was
higher than in the colon tissue (p<0.001, Figure 2). Re-
sults of Western blots were quantified by densitometric
analysis and results of this analysis demonstrated a
1.5-fold higher expression of Reg IV in the spleen. Colon
showed low expression level in all examined extracts.
In normal colonic mucosa, Reg IV was expressed in a
few epithelial cells in the basal portion of Lieberkühn
crypts (Figure 3). We found that Reg IV positive cells
were mainly present in the lower part of the crypts in co-
lonic mucosa. Expression of Reg IV was not detected in





Fig. 1. Western blot with Reg IV antibody showing a band with
the 20 kDa expected size, respectively. Lane 1 = spleen;



























Fig. 2. Results of Western blots were quantified by densitometric
analysis and represented as the X ± SEM, black bar: spleen;
white bar: colon. * significance at p < 0.05 comparing spleen ver-
sus colon values.
stromal cells (Figure 3). High magnification showed that
immunoreactive Reg IV protein was stained in a fine
granular pattern in the cytoplasm of epithelial cells (data
not shown).
In normal spleen tissue, Reg IV was expressed in a
few cells which were scattered in the red pulp. Reg IV
immunoreactivity was observed in the certain large spleen
cells with a large nucleus (Figure 4). High magnification
showed that Reg IV immunoreactivity was detected in
the cytoplasm of large spleen cells (data not shown).
Discussion
Our study demonstrated that Reg IV protein was ex-
pressed in the spleen and colon tissue of the rat. We
showed histologically that in the normal colon Reg IV
protein is expressed in a few epithelial cells in the basal
portion of Lieberkühn crypts. This finding is compatible
with the observation by Nanakin et al.4 that showed that
these epithelial cells showing neuroendocrine features
and suggests that Reg IV expression may be associated
with proliferative behavior of epithelial cells in the colon
mucosa. Interestingly, in the colon epithelium, Reg Ia is
expressed in only a few small cells in the basal portion of
a colonic crypt where putative stem cells reside15. These
data strongly suggest that Reg proteins may play a role
in the self renewal of colonic mucosa under certain physi-
ological conditions. Recently, using the polymerase chain
reaction technique, Namikawa et al.14 investigated the
expression of the Reg family members, including the Reg
IV, in response to rat hypoglossal nerve injury and re-
vealed that there is no expression of the Reg IV mRNA in
either the normal or injured hypoglossal nerve. Reg IV
mRNA has been found to be expressed in the human gas-
trointestinal tract, including colon, small intestine, sto-
mach and pancreas6. Although some normal human tis-
sues express Reg IV, levels of Reg IV expression are much
lower in normal than in tumor tissues. Overexpression of
Reg IV mRNA was detected in colorectal adenocarci-
noma and adenoma9,4, in inflammatory and metaplastic
gastrointestinal mucosa13,16, in gastric cancer17, in pros-
tate cancer12 and pancreatic cancer10. Our results showed
that the Reg IV protein expression is higher in the rat
spleen than in the colon. The weak expression of the Reg
IV protein in the colon allows us to speculate that the
level of Reg IV is different in various normal rat tissues.
The presence of Reg IV protein in culture medium stimu-
lated cell proliferation in dose dependent manner, which
indicates that Reg IV could promote cell proliferation in
an autocrine/paracrine manner. Bishnupuri et al.18 have
found that Reg IV is a novel mediator which increase ac-
tivation of the epidermal growth factor receptor (EGFR)/
phosphoinositide 3-kinase/Akt signaling pathway. EGFR
activation are associated with poor prognosis from a nu-
merous of malignancies and are linked to increased inva-
siveness of the carcinomas and resistance to apoptotic
cell death. The presence of the Reg IV in the rat spleen
and colon is the first demonstration of such a high level
of Reg IV protein expression in rat normal tissues. It has
been demonstrated Reg IV protein expression in the hu-
man colon. Immunohistochemical analysis performed on
the colon tissue showed only weak or no expression of
Reg IV in epithelial cells but strong expression of Reg IV
was detected in neuroendocrine cells11. Even though, the
Reg IV is expressed by cells of the intestinal epithelium
which comprises the proliferating cells, Reg IV mRNA is
also abundant in the non dividing cells of the intestinal
mucosa. Their expression has been associated with pro-
liferation, cell survival and resistance to apoptosis11. In
the present study, we have shown that Reg IV protein is
expressed in a large spleen cells which were scattered in
the red pulp. Expression of the Reg IV protein in the rat
spleen raises question about its function in that organ.
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Fig. 3. Result of immunohistochemical staining for Reg IV pro-
tein in rat colon. Histological section was stained with anti-Reg
IV polyclonal antibody. Reg IV immunoreactive signal was de-
tected in a few epithelial cells in the basal portion of crypts (ar-
rows). Original magnification: ´40.
Fig. 4. Result of immunohistochemical staining for Reg IV pro-
tein in rat spleen. Histological section was stained with anti-Reg
IV polyclonal antibody. Reg IV immunoreactive signal was de-
tected in a large spleen cells in the red pulp (arrows). Original
magnification: ´40.
As it is well known the spleen is acting as a part of the
immune system. The white pulp of the spleen is made up
mainly of lymphocytes while the red pulp contains mainly
red blood cells and macrophages. Partial removal of the
spleen tissue is followed by rapid regeneration of the
tissue19. Faustman’s team20 have found that the spleen
might be a source of adult stem cells that could regener-
ate the pancreatic b-cells. Lonyai et al.21 showed that
adult human spleen contain a reservoir of multilineage
adult stem cells that expressed the developmental tran-
scription factor Hox11. Hox11 is a controller of key steps
in embryonic development of the spleen and contribute
to development of hindbrain, pancreas, salivary glands
and other organs and tissues. Although, their role in hu-
mans is not known, Hox11 stem cells from the mice
spleen which is infused into diseased NOD mice differen-
tiate into the pancreatic b-cells21. Because all this facts
we can only assume the potential role of the Reg IV pro-
tein in spleen cell growth. Also, other members of the
Reg family, Reg I and Reg III proteins have been shown
to act as growth factors in gastrointestinal tract. Reg IV
may be a potential candidate marker of stem cells in the
spleen. We would like to emphasize the necessity for fur-
ther investigations to establish the localization and the
biological role of the Reg IV in the spleen cells and also in
cells of different rat organs. We can only assume that bio-
logical role of Reg IV and other Reg genes are similar. For
example, some Reg genes are involved in regeneration
process of many organs and are highly expressed in vari-
ous pathological processes. It would be very interesting
to investigate the expression of Reg IV during skeletal
muscle regeneration and muscular atrophy22,23 since we
know that skeletal muscle has ability to be repaired upon
injury and to induce a proliferation of progenitor satellite
cells, the process which is mediated by nitric oxide (NO)
release24.
Conclusion
Our results demonstrate for the first time the Reg IV
protein expression in the rat spleen and colon tissue. Ex-
pression of Reg IV protein in spleen tissue is significantly
higher than in the colon tissue which suggests the differ-
ent protein level in various organs. We believe that Reg
IV has potential role in growth and proliferation of the
spleen and colon cells like the other members of the Reg
family which acts as a growth factors in the gastrointesti-
nal tract.
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EKSPRESIJA REG IV PROTEINA U NORMALNOM TKIVU [TAKORA
S A @ E T A K
Reg IV gen je dokazan u humanom tkivu kolona, tankog crijeva, `eluca i gu{tera~e. Ispoljavanje Reg IV gena u
razli~itim tipovima stanica je povezano sa procesom stani~ne regeneracije, rastom i pre`ivljavanjem stanica, procesima
stani~ne adhezije te otporno{}u na apoptozu. Do sada nije istra`eno ispoljavanje Reg IV proteina u normalnim tkivima
{takora. Cilj ovog istra`ivanja je odrediti ispoljavanje Reg IV proteina u tkivu slezene i kolona kod {takora. Upotrebom
Western blot analize i imunohistokemijske metode dokazali smo Reg IV protein u ekstraktima tkiva slezene i kolona
koriste}i poliklonalno protutijelo specifi~no za Reg IV protein. Rezultati Western blot analize su kvantificirani den-
zitometrijskom metodom i pokazuju vi{u razinu ispoljavanja Reg IV proteina u tkivu slezene u odnosu na tkivo kolona.
Imunohistokemijska metoda je pokazala ekspresiju Reg IV proteina u nekoliko epitelnih stanica smje{tenih na dnu
kripti kolona te ekspresiju u velikim stanicama slezene koje su ra{trkane u crvenoj pulpi slezene. Na{i rezultati su po
prvi puta pokazali prisutnost Reg IV proteina u normalnoj slezeni i kolonu {takora. Iako Reg IV protein pripada skupini
Reg obitelji za koje se zna da djeluju kao faktori rasta u organima gastrointestinalnog trakta, daljnja istra`ivanja su
potrebna da bi se ustanovila biolo{ka uloga Reg IV proteina u stanicama slezene.
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